1. Home
  2. MBWM vs CMPX Comparison

MBWM vs CMPX Comparison

Compare MBWM & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mercantile Bank Corporation

MBWM

Mercantile Bank Corporation

HOLD

Current Price

$51.13

Market Cap

900.2M

Sector

Finance

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$1.84

Market Cap

927.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBWM
CMPX
Founded
1997
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
900.2M
927.5M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
MBWM
CMPX
Price
$51.13
$1.84
Analyst Decision
Buy
Strong Buy
Analyst Count
3
9
Target Price
$55.67
$14.57
AVG Volume (30 Days)
86.0K
12.2M
Earning Date
04-21-2026
05-06-2026
Dividend Yield
3.08%
N/A
EPS Growth
10.95
N/A
EPS
1.32
N/A
Revenue
N/A
N/A
Revenue This Year
$20.28
N/A
Revenue Next Year
$4.67
$934.41
P/E Ratio
$37.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$42.17
$1.61
52 Week High
$55.77
$6.88

Technical Indicators

Market Signals
Indicator
MBWM
CMPX
Relative Strength Index (RSI) 48.88 26.23
Support Level $49.17 $1.61
Resistance Level $54.90 $3.54
Average True Range (ATR) 1.30 0.15
MACD -0.12 0.06
Stochastic Oscillator 50.23 46.05

Price Performance

Historical Comparison
MBWM
CMPX

About MBWM Mercantile Bank Corporation

Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: